These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 19191803

  • 1. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
    Yoon HE, Kim SH, Kim JY, Oh EJ, Park SC, Choi BS, Choi YJ, Moon IS, Kim YS, Yang CW.
    Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
    [Abstract] [Full Text] [Related]

  • 2. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [Abstract] [Full Text] [Related]

  • 3. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK.
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [Abstract] [Full Text] [Related]

  • 4. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure.
    Wang R, Wang H, Chen J, Wu J, Wang Y, Huang H, He Q.
    Nephrology (Carlton); 2009 Aug; 14(5):527-32. PubMed ID: 19674321
    [Abstract] [Full Text] [Related]

  • 5. The significance of C4d staining with minimal histologic abnormalities.
    Haas M.
    Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
    [Abstract] [Full Text] [Related]

  • 6. C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients: single-center incidence and outcome.
    Valente M, Furian L, Marchini F, Marino S, Cardillo M, Rigotti P, Aiello FB.
    Transplant Proc; 2010 Feb; 42(6):2214-7. PubMed ID: 20692447
    [Abstract] [Full Text] [Related]

  • 7. Effects of hypoxia-inducible factor-1alpha expression and C4d deposition in implantation biopsies on renal allograft.
    Kim DJ, Lee S, Kim SJ, Park SG, Kim JS, Hyun SJ, Song YS, Nam ES.
    Transplant Proc; 2008 Sep; 40(7):2145-6. PubMed ID: 18790175
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition.
    Imai N, Nishi S, Alchi B, Ueno M, Fukase S, Arakawa M, Saito K, Takahashi K, Gejyo F.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2589-95. PubMed ID: 16644773
    [Abstract] [Full Text] [Related]

  • 9. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF, Fernández R, Fernández D, Jaramillo JC, Gil M, López García-Asenjo JA.
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [Abstract] [Full Text] [Related]

  • 10. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K, Yamaguchi Y, Shimizu T, Horita S, Furusawa M, Tanabe K, Fuchinoue S, Toma H.
    Clin Transplant; 2004 Jun; 18 Suppl 11():7-12. PubMed ID: 15191366
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complement C4d deposition in transplanted kidneys: preliminary report on long-term graft survival.
    Kawamura N, Tomita M, Hasegawa M, Murakami K, Nabeshima K, Kushimoto H, Kasugai M, Takahashi K, Hiki Y, Kinukawa T, Usuda N, Sugiyama S.
    Clin Transplant; 2005 Jun; 19 Suppl 14():27-31. PubMed ID: 15955166
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients.
    Cheunsuchon B, Vongwiwatana A, Premasathian N, Shayakul C, Parichatikanond P.
    Transplant Proc; 2009 Nov; 41(9):3697-700. PubMed ID: 19917370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
    Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal Ø, Mollnes TE.
    Transplantation; 2003 Apr 27; 75(8):1204-13. PubMed ID: 12717204
    [Abstract] [Full Text] [Related]

  • 16. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.
    Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897
    [Abstract] [Full Text] [Related]

  • 17. Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation.
    Namba Y, Oka K, Moriyama T, Kyo M, Imamura R, Shi Y, Ichimaru N, Isaka Y, Takahara S, Okuyama A.
    Clin Transplant; 2006 Jan 15; 20 Suppl 15():20-5. PubMed ID: 16848871
    [Abstract] [Full Text] [Related]

  • 18. C4d as a significant predictor for humoral rejection in renal allografts.
    Jianghua C, Wenqing X, Huiping W, Juan J, Jianyong W, Qiang H.
    Clin Transplant; 2005 Dec 15; 19(6):785-91. PubMed ID: 16313326
    [Abstract] [Full Text] [Related]

  • 19. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I, Alvarez-Marquez A, Gentil MA, Fernandez-Alonso J, Fijo J, Saez C, Wichmann I, Nuñez-Roldan A.
    Nephrol Dial Transplant; 2008 Jul 15; 23(7):2393-8. PubMed ID: 18308775
    [Abstract] [Full Text] [Related]

  • 20. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.
    Transplant Proc; 2007 Nov 15; 39(9):2718-20. PubMed ID: 18021967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.